EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

NRG Oncology White Paper on the Relative Biological Effectiveness in Proton Therapy

Harald Paganetti, Charles B Simone, Walter R Bosch, Daphne Haas-Kogan, David G Kirsch, Heng Li, Xiaoying Liang, Wei Liu, Anita Mahajan, Michael D Story, Paige A Taylor, Henning Willers und 2 weitere

International Journal of Radiation Oncology*Biology*Physics · 2025

DOI: 10.1016/j.ijrobp.2024.07.2152 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Harald Paganetti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; Department of Radiation Oncology, Harvard Medical School, Bo…. Hauptthemen laut MEDLINE: Proton Therapy, Relative Biological Effectiveness, Linear Energy Transfer, Neoplasms. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This position paper, led by the NRG Oncology Particle Therapy Work Group, focuses on the concept of relative biologic effect (RBE) in clinical proton therapy (PT), with the goal of providing recommendations for the next-generation clinical trials with PT on the best practice of investigating and using RBE, which could deviate from the current standard proton RBE value of 1.1 relative to photons. In part 1, current clinical utilization and practice are reviewed, giving the context and history of RBE. Evidence for variation in RBE is presented along with the concept of linear energy transfer (LET). The intertwined nature of tumor radiobiology, normal tissue constraints, and treatment planning with LET and RBE considerations is then reviewed. Part 2 summarizes current and past clinical data and then suggests the next steps to explore and employ tools for improved dynamic models for RBE. In part 3, approaches and methods for the next generation of prospective clinical trials are explored, with the goal of optimizing RBE to be both more reflective of clinical reality and also deployable in trials to allow clinical validation and interpatient comparisons. These concepts provide the foundation for personalized biologic treatments reviewed in part 4. Finally, we conclude with a summary including short- and long-term scientific focus points for clinical PT. The practicalities and capacity to use RBE in treatment planning are reviewed and considered with more biological data in hand. The intermediate step of LET optimization is summarized and proposed as a potential bridge to the ultimate goal of case-specific RBE planning that can be achieved as a hypothesis-generating tool in near-term proton trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton TherapyRelative Biological EffectivenessLinear Energy TransferNeoplasmsHumansOrgans at RiskClinical Trials as TopicRadiation OncologyRadiotherapy Planning, Computer-Assisted

Autor:innen und Institutionen

  • Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts.
  • New York Proton Center, New York, New York; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Radiation Oncology, Washington University, St. Louis, Missouri.
  • Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston Children's Hospital, Boston, Massachu…
  • Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland.

Förderung

  • NCI NIH HHS

Zitieren

APA

Paganetti, H., Simone, C. B., Bosch, W. R., Haas-Kogan, D., Kirsch, D. G., Li, H., Liang, X., Liu, W., Mahajan, A., Story, M. D., Taylor, P. A., Willers, H., Xiao, Y., & Buchsbaum, J. C. (2025). NRG Oncology White Paper on the Relative Biological Effectiveness in Proton Therapy. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2024.07.2152

Vancouver

Paganetti H, Simone CB, Bosch WR, Haas-Kogan D, Kirsch DG, Li H, et al. NRG Oncology White Paper on the Relative Biological Effectiveness in Proton Therapy. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2024.07.2152

BibTeX
@article{Paganetti2025,
  author = {Paganetti, Harald and Simone, Charles B and Bosch, Walter R and Haas-Kogan, Daphne and Kirsch, David G and Li, Heng and Liang, Xiaoying and Liu, Wei and Mahajan, Anita and Story, Michael D and Taylor, Paige A and Willers, Henning and Xiao, Ying and Buchsbaum, Jeffrey C},
  title = {NRG Oncology White Paper on the Relative Biological Effectiveness in Proton Therapy},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2025},
  doi = {10.1016/j.ijrobp.2024.07.2152}
}
Kostenlos starten →